Jonathan B. Rothbard serves as Executive at 180 Life Sciences Corp., where they oversee executive responsibilities. Since joining the company, Jonathan B. Rothbard has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 7, 2021 involved receiving (via award) 24,307 shares valued at $149.2K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 7, 2021 | ATNF | $149.2K | Award | 24,307 | $6.14 | Discretionary |
Jonathan B. Rothbard currently holds 560,449 shares of 180 Life Sciences Corp. (ATNF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan B. Rothbard has been a net neutral trader of ATNF stock. They have purchased $0 and sold $0 worth of shares.
Jonathan B. Rothbard's most recent insider trade was on Apr 7, 2021, when they sold 24,307 shares at $6.14 per share.
Get notified when new Form 4 filings are submitted